CUSIP: 37185R208
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / SPON ADR 150SHS
-
Total 13F shares
-
1,203,793
-
Share change
-
+154,630
-
Total reported value
-
$1,250,083
-
Price per share
-
$1.04
-
Number of holders
-
13
-
Value change
-
+$160,255
-
Number of buys
-
7
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 37185R208:
Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q1 2018
As of 31 Mar 2018,
GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,203,793 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, Alpine Global Management, LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Cambridge Investment Research Advisors, Inc., Parallax Volatility Advisers, L.P., Cutler Group LP, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.